Cannabis company Acreage names former Procter Gamble exec ... - Morningstar
| BUDZ Stock | USD 0.03 0.01 19.75% |
Slightly above 62% of Weed's investor base is looking to short. The analysis of current outlook of investing in Weed Inc suggests that many traders are alarmed regarding Weed's prospects. Weed's investing sentiment can be driven by a variety of factors including economic data, Weed's earnings reports, geopolitical events, and overall market trends.
Weed |
Cannabis company Acreage names former Procter Gamble exec ... Morningstar
Read at news.google.com
 |
Weed Fundamental Analysis
We analyze Weed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Weed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Weed based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Weed is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Weed Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Weed otc stock to make a market-neutral strategy. Peer analysis of Weed could also be used in its relative valuation, which is a method of valuing Weed by comparing valuation metrics with similar companies.
Peers
Weed Related Equities
| OGI | OrganiGram Holdings | 6.85 | ||||
| GRUSF | Grown Rogue | 1.52 | ||||
| DERM | Journey Medical | 0.65 | ||||
| AAWH | Ascend Wellness | 4.35 | ||||
| CXXIF | C21 Investments | 5.00 | ||||
| CRLBF | Cresco Labs | 6.38 |
Additional Tools for Weed OTC Stock Analysis
When running Weed's price analysis, check to measure Weed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Weed is operating at the current time. Most of Weed's value examination focuses on studying past and present price action to predict the probability of Weed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Weed's price. Additionally, you may evaluate how the addition of Weed to your portfolios can decrease your overall portfolio volatility.